• Follow:
info@cagfunds.com
  • Home
  • News
  • About Us
    • Funds
    • Management
    • Who We Are
    • Distinction
    • Our Values
    • Strategy
    • Testimonials
    • Investment Banking
  • Services
  • PARTNERS
  • CAREERS
  • CONTACT
  • INVESTORS
Search Button
HomeLatest News Managing Director Tarek Choufani signs an Agreement with Truffle Capital to set up a dedicated BioMedTech Fund.
January 6, 2020

Managing Director Tarek Choufani signs an Agreement with Truffle Capital to set up a dedicated BioMedTech Fund.

Managing Director Tarek Choufani signs an Agreement with Truffle Capital to set up ‘TNC BioMedTech Fund’. This Fund will be managed by Truffle Capital under the supervision of CAGF. Its focus will be early-stage investment in
Truffle Capital’s BioMedTech deal pipeline.

Previous News

Senator Ladislas Poniatowski hosts Mr. Najib Choufani in the Senate of France.

Next News

Chairman Najib Choufani is invited to Elysée presidential palace for a meeting with the senior consultant to President Macron to discuss accessing capital via Saudi PIF.
More About Us
  • Funds
  • Management
  • Who We Are
  • Our Values
  • Strategy
  • Investment Banking
Practice Areas
  • Business Consulting
  • Financial Marketing
  • Capital Formation
  • Mezannine Financing
  • Equity Financing
Latest News
  • Chairman Najib Choufani is invited to Elysée presidential palace for a mee…
    February 11, 2020
  • Managing Director Tarek Choufani signs an Agreement with Truffle Capital t…
    January 6, 2020
  • Senator Ladislas Poniatowski hosts Mr. Najib Choufani in the Senate of Fran…
    July 19, 2019
  • CIO of CAG Funds, Mr. Curtis Lefkowitz, signs Cooperation Agreement with th…
    June 2, 2019
  • CAG Funds launches new office in Beijing for its entertainment fund Visionm…
    May 25, 2019
Copyright © 2021 CAGF Group. All Rights Reserved.
  • Follow: